Acute Lung Injury clinical trials at UCSF
2 in progress, 1 open to eligible people
Acute lung injury is a serious lung problem. UCSF is studying a treatment that involves cells from bone marrow. These cells are given through an IV to see if they are safe and work well.
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
open to eligible people ages 18-75
To evaluate the safety and efficacy of intravenous (IV) administration of bone marrow mesenchymal stem cell derived extracellular vesicles (EVs), ExoFlo, versus placebo for the treatment of hospitalized patients with moderate-to-severe Acute Respiratory Distress Syndrome (ARDS).
San Francisco, California and other locations
PROSpect: Prone and Oscillation Pediatric Clinical Trial
Sorry, accepting new patients by invitation only
Severe pediatric acute respiratory distress syndrome (PARDS) is a life-threatening and frequent problem experienced by thousands of children each year. Little evidence supports current supportive practices during their critical illness. The overall objective of this study is to identify the best positional and/or ventilation practice that leads to improved patient outcomes in these critically ill children. We hypothesize that children with high moderate-severe PARDS treated with either prone positioning or high-frequency oscillatory ventilation (HFOV) will demonstrate more days off the ventilator when compared to children treated with supine positioning or conventional mechanical ventilation (CMV).
San Francisco, California and other locations
Last updated: